• Sensus Healthcare posted a net loss of USD 2.63 million for Q1 2026, versus a net loss of USD 2.57 million a year earlier.
• Revenue fell 59% to USD 3.39 million, reflecting 10 units sold; some systems were placed under Fair Deal Agreement program and rental arrangements with revenue recognized over the contract term.
• Operating loss widened to USD 4.36 million as gross margin dropped 23.6 percentage points to 29.4%.
• Cash and cash equivalents declined to USD 18.3 million as of March 31, 2026, from USD 22.1 million at year-end, with operating cash outflow of USD 3.75 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sensus Healthcare Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001753926-26-000845), on May 13, 2026, and is solely responsible for the information contained therein.